Visine Advance Extended Relief
Natural health product licensed in Canada
- Licence holder
- Kenvue Canada Inc.
- NPN or DIN-HM
- 80007323
- Status
- Inactive licence
- Licence date
- 29 August 2008
- Revision date
- Not provided
- Form
- Solution
- Route of administration
- Ophthalmique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Hyaluronate de sodium Source : Fermentation bactérienne | 0.1 % (p/p) |
Non-medicinal ingredients
Sorbitol, Sodium Phosphate, Dibasic (dihydrate), Eau pour injection, Sodium Phosphate, Dibasic (dodecahydrate)
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 16 years | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | Not specified |
| Adultes | Not specified | minimum: 1 Goutte(s) ; maximum: 2 Goutte(s) | Not specified |
Uses authorised in Canada
For temporary relief of discomfort, including burning, grittiness and irritation due to dryness of the eye. For temporary moisturization and lubrication of the eye to protect against further irritation. Temporary relief of dryness and discomfort from contact lens wear. For rewetting lenses to minimize dryness. Advanced formula lubrication for extra soothing relief of dry eyes. Retains tears on eye. Slows evaporation and tear film break up time. For relief of dry, irritated eyes.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80007323
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.